Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome (Q61241): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A síndrome de Kearns-Sayre é uma doença neuromuscular mitocondrial rara, geralmente esporádica, caracterizada por perda auditiva neurossensorial progressiva, oftalmoplegia, ptose, retinite pigmentar e envolvimento do sistema nervoso central (ataxia cerebelar, disartria, fraqueza facial bilateral, déficit intelectual), bem como cardiomiopatia hipertrófica e defeitos de condução cardíaca. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/605176031 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_605176031 | |||||||||||||||
| Property / CURIE: CID11:ID_605176031 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_605176031 | |||||||||||||||
| Property / Canary Token: dki-india-ID_605176031 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 08:43, 14 August 2026
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_605176031 |
||
| English | Hypertrophic cardiomyopathy due to Kearns–Sayre syndrome |
Kearns-Sayre syndrome is a rare mitochondrial neuromuscular disease, usually sporadic, characterised by progressive sensorineural hearing loss, ophthalmoplegia, ptosis, pigmentary retinitis, and central nervous system involvement (cerebellar ataxia, dysarthria, bilateral facial weakness, intellectual deficit),as well as hypertrophic cardiomyopathy and cardiac conduction defects. |
Statements
CID11:ID_605176031
0 references
dki-india-ID_605176031
0 references
Concluído
0 references
13 August 2026
0 references
